✦ LIBER ✦
Crohn's Disease: Infliximab Trough Levels and CRP During Infliximab-Immunomodulator Combination Treatment Are Associated With Clinical Outcome After Immunomodulator Withdrawal
✍ Scribed by David Drobne; Peter J. Bossuyt; Christine Breynaert; Niels Vande Casteele; Griet Compernolle; Matthias Jürgens; Vera Ballet; Willem-jan Wollants; Isabelle Cleynen; Paul J. Rutgeerts; Severine Vermeire; Ann Gils; Gert A. Van Assche
- Book ID
- 119432101
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 180 KB
- Volume
- 140
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.